BRACE Award Venture Competition

Friday Morning, 6 November 2020, Hong Kong Time

The BRACE Award Venture Competition Judging Committee is comprised of a combination of world-class life sciences industry professionals, investors and entrepreneurs from within the extensive network of the Asian Fund for Cancer Research (AFCR). Its members will determine two finalists among the event’s semi-finalists. The winner will receive the equivalent of HK$2,000,000 in investment funding from AFCR, which will serve as early seed money for proof of concept and proof of value on the path to clinical trials and, eventually, to new effective therapeutics that could save patients’ lives.

Ready to do more? DONATE NOW and help us double the impact for early-stage oncology start-ups that are creating life-saving innovations!

Raju Kucherlapati, Ph.D., Chair
Paul C. Cabot Professor of Genetics & Professor of Medicine, Harvard Medical School

Webster Cavenee, Ph.D.
Director of Strategic Alliances, Ludwig Institute for Cancer Research, Distinguished Professor of Medicine, University of California San Diego

Pamela Garzone, Ph.D.
Chief Medical Officer, Calibr at Scripps Research

Brian Leyland-Jones, Ph.D.
Chief Medical Officer, AIM-HI Accelerator Fund

Kanaga Sabapathy, Ph.D.
Head, Division of Cellular and Molecular Research, National Cancer Center Singapore

Alfred Slanetz, Ph.D.
President & CEO, Geneius Biotechnology, Inc.

Michael Wang

Michael Wang, M.D., MBA, Ph.D.
Chief Strategy Officer, National Foundation for Cancer Research

Wai-Kwan Alfred Yung, M.D.
Professor, Department of Neuro-Oncology, University of Texas, MD Anderson Cancer Center